Agreement of Antipsychotic Use between Nursing Home Electronic Records and Minimum Data Set.
Tingting Zhang, Ellen McCreedy, Laura Dionne and 2 others
PMID 37573885WHAT IT FOUND
In 604 nursing home residents with dementia, Minimum Data Set records matched electronic medication administration records closely for antipsychotic use and days used.
This supports using MDS medication entries to monitor antipsychotic use in these facilities.
Key findings
01In 604 residents with dementia in 35 nursing homes, MDS records identified antipsychotic use in 29.5% and eMAR records identified use in 28.3% during a 7-day window.
02Of 171 eMAR-identified antipsychotic users, 98.8% were also MDS users; of 178 MDS-identified users, 94.9% were also eMAR users.
03Average antipsychotic treatment days were 2.0 by MDS and 1.8 by eMAR.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study included only residents with dementia, so it does not show agreement for other nursing home residents. Only three nursing home corporations were included, and the paper notes limited generalizability. The MDS look-back was 7 days, so intermittent antipsychotic use outside that week was not assessed. The study measured agreement between records, not clinical appropriateness of antipsychotic use. The methods say eMAR data were available from 34 nursing homes, while the results say 35 nursing homes were included.
Declared interests
All co-authors reported no conflicts of interest. The study is categorized as NIH extramural research support.
The easy way to misread this
Do not conclude that MDS records are valid for all nursing homes or all medications. The agreement was only for antipsychotic use in 604 residents with dementia from three nursing home corporations.